SPONSOR
National Health Research Institutes, Taiwan
Total Trials
2
Recruiting
2
Phases
Phase 1, Phase 2
Conditions studied: Metastatic Gastric AdenocarcinomaSecond LineChemotherapyPrimary Malignant Brain Tumors
National Health Research Institutes, Taiwan is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Metastatic Gastric Adenocarcinoma, Second Line, Chemotherapy, Primary Malignant Brain Tumors.
The trial portfolio spans Phase 1, Phase 2 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — National Health Research Institutes, Taiwan
How many clinical trials has National Health Research Institutes, Taiwan sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by National Health Research Institutes, Taiwan, of which 2 are actively recruiting participants. These trials cover conditions including Metastatic Gastric Adenocarcinoma, Second Line, Chemotherapy. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does National Health Research Institutes, Taiwan research focus on?
National Health Research Institutes, Taiwan clinical trials span Metastatic Gastric Adenocarcinoma, Second Line, Chemotherapy, Primary Malignant Brain Tumors. The research pipeline includes Phase 1, Phase 2 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a National Health Research Institutes, Taiwan clinical trial?
To participate in a National Health Research Institutes, Taiwan trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all National Health Research Institutes, Taiwan trials with current recruitment status updated daily.
Clinical Trials by National Health Research Institutes, Taiwan
NCT05927857 Phase 1, Phase 2
Recruiting
Ramucirumab (Cyramza), Nal-IRI (ONIVYDE) and Trifluridine/Tipiracil (Lonsurf) in Second Line Metastatic Gastric Cancer .
Metastatic Gastric Adenocarcinoma
NCT05622409
Recruiting
A Taiwanese Oncogenetic Panel and Integrated Clinical Data Registry Study for Diffuse Glioma
Primary Malignant Brain Tumors
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: July 2026 · Data Methodology